Iscodil (Clopidogrel)

Clopidogrel is converted in the liver to an active metabolite that irreversibly blocks the platelet P2Y12 ADP receptor. This inhibition stops ADP‑mediated activation of the GPIIb/IIIa complex, preventing platelets from aggregating and forming clots. The effect lasts for the lifespan of each platelet, providing continuous antithrombotic protection.

The appropriate dose of Iscodil is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal and hepatic function, and concomitant therapies. Dosage recommendations are outlined in the product’s prescribing information and should not be altered without medical guidance.

Safety data for clopidogrel during pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment options with their physician.

To request Iscodil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Both clopidogrel (Iscodil) and aspirin inhibit platelet aggregation, but they act on different pathways. Aspirin irreversibly blocks cyclooxygenase‑1, reducing thromboxane A2, while clopidogrel targets the P2Y12 ADP receptor. Clopidogrel is often preferred when aspirin alone is insufficient or when patients have aspirin intolerance, offering a more potent antiplatelet effect in many cardiovascular settings.

Iscodil tablets should be stored at ambient temperature below 25 °C, kept in the original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer, and keep out of reach of children.

Iscodil is taken orally, usually with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not crushed, chewed, or split unless specifically advised by the prescriber.

The most critical safety concerns with Iscodil involve bleeding complications, including gastrointestinal hemorrhage and intracranial bleeding. Patients should also be alert for signs of severe skin reactions, unexplained bruising, or a sudden drop in platelet count, and report any such symptoms promptly to their physician.

Iscodil is contraindicated in individuals with active pathological bleeding, known hypersensitivity to clopidogrel or any component of the formulation, and in patients who are currently receiving certain strong CYP2C19 inhibitors that markedly reduce its effectiveness. Clinicians should also exercise caution in patients with severe hepatic impairment.